Erythrocyte glutathione levels as long-term predictor of transition to psychosis

por Lavoie, S, Berger, M, Schlögelhofer, M, Schäfer, M R, Rice, S, Kim, S-W, Hesse, J, McGorry, P D, Smesny, S, Amminger, G P
Publicado en Transl Psychiatry (2017)

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

por Amminger, G P, Mechelli, A, Rice, S, Kim, S-W, Klier, C M, McNamara, R K, Berk, M, McGorry, P D, Schäfer, M R
Publicado en Transl Psychiatry (2015)

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

por Berger, M E, Smesny, S, Kim, S-W, Davey, C G, Rice, S, Sarnyai, Z, Schlögelhofer, M, Schäfer, M R, Berk, M, McGorry, P D, Amminger, G P
Publicado en Transl Psychiatry (2017)

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

por Clark, S R, Baune, B T, Schubert, K O, Lavoie, S, Smesny, S, Rice, S M, Schäfer, M R, Benninger, F, Feucht, M, Klier, C M, McGorry, P D, Amminger, G P
Publicado en Transl Psychiatry (2016)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

por Bousman, C A, Yung, A R, Pantelis, C, Ellis, J A, Chavez, R A, Nelson, B, Lin, A, Wood, S J, Amminger, G P, Velakoulis, D, McGorry, P D, Everall, I P, Foley, D L
Publicado 2013

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

por Cotton, S. M., Berk, M., Watson, A., Wood, S., Allott, K., Bartholomeusz, C. F., Bortolasci, C. C., Walder, K., O’Donoghue, B., Dean, O. M., Chanen, A., Amminger, G. P., McGorry, P. D., Burnside, A., Uren, J., Ratheesh, A., Dodd, S.
Publicado en Trials (2019)

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

por Di Biase, M A, Zalesky, A, O'keefe, G, Laskaris, L, Baune, B T, Weickert, C S, Olver, J, McGorry, P D, Amminger, G P, Nelson, B, Scott, A M, Hickie, I, Banati, R, Turkheimer, F, Yaqub, M, Everall, I P, Pantelis, C, Cropley, V
Publicado en Transl Psychiatry (2017)

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical cour...

por Nelson, B., Amminger, G. P., Yuen, H. P., Markulev, C., Lavoie, S., Schäfer, M. R., Hartmann, J. A., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G., Chen, E. Y. H., de Haan, L., Nieman, D. H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A. R., McGorry, P. D.
Publicado en NPJ Schizophr (2018)